The antinociceptive interaction of anandamide and adenosine at the spinal level

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 3, 2009, Pages 374-379

  Tuboly, Gabor ^a   Kekesi, Gabriella ^a   Nagy, Edit ^b   Benedek, György ^a   Horvath, Gyöngyi ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Adenosine; Anandamide; Caffeine; Cannabinoid; Endogenous; Hyperalgesia; Intrathecal; TRPV1

Indexed keywords

ADENOSINE; ANANDAMIDE; CAFFEINE; CARRAGEENAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; LATENT PERIOD; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ADENOSINE; ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HOT TEMPERATURE; INFLAMMATION; INJECTIONS, SPINAL; MALE; PAIN; PAIN MEASUREMENT; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, PURINERGIC P1;

RATTUS NORVEGICUS;

EID: 57449116132     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.08.010     Document Type: Article

References (72)

1. Ahluwalia J., Urban L., Capogna M., Bevan S., and Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100 (2000) 685-688
2. Ahluwalia J., Urban L., Bevan S., and Nagy I. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci 17 (2003) 2611-2618
3. Bach F.W., and Yaksh T.L. Release of b-endorphin immunoreactivity into ventriculo-cisternal perfusate by lumbar intrathecal capsaicin in the rat. Brain Res 701 (1995) 192-200
4. Begg M., Dale N., Llaudet E., Molleman A., and Parsons M.E. Modulation of the release of endogenous adenosine by cannabinoids in the myenteric preparation of the guinea-pig plexus-longitudinal muscle ileum. Br J Pharmacol 137 (2002) 1298-1304
5. Bolcskei K., Helyes Z., Szabo A., Sandor K., Elekes K., Nemeth J., et al. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 117 (2005) 368-376
6. Breese N.M., George A.C., Pauers L.E., and Stucky C.L. Peripheral inflammation selectively increases TRPV1 function in IB4-positive sensory neurons from adult mouse. Pain 115 (2005) 37-49
7. Cahill C.M., White T.D., and Sawynok J. Influence of calcium on the release of endogenous adenosine from spinal cord synaptosomes. Life Sci 53 (1993) 487-496
8. Camann W.R., Murray S., Mushlin P.S., and Lambert D.H. Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial. Anesth Analg 70 (1990) 181-184
9. Carlini E.A. The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol ([Delta]9-THC) on humans. Toxicon 44 (2004) 461-467
10. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., et al. Impaired nociception and pain sensitisation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
11. Chiari A., and Eisenach J.C. Intrathecal adenosine: interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative hypersensitivity. Anesthesiology 90 (1999) 1413-1421
12. Chiari A., Yaksh T.L., Myers R.R., Provencher J., Moore L., Lee C.S., et al. Preclinical toxicity screening of intrathecal adenosine in rats and dogs. Anesthesiology 91 (1999) 824-832
13. Chung K.M., Choi S.S., Choi M.R., and Suh H.W. Effects of spinally and supraspinally injected 3-isobutyl-1-methylxanthine, cholera toxin, and pertussis toxin on immobilization stress-induced antinociception in the mouse. Eur Neuropsychopharmacol 13 (2003) 281-288
14. Coggeshall R.E., and Carlton S.M. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res Rev 24 (1997) 28-66
15. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76 (1994) 5-13
16. Dar M.S. Cerebellar CB1 receptor mediation of Delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse. Brain Res 864 (2000) 186-194
17. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
18. Di Marzo V., Blumberg P.M., and Szallasi A. Endovanilloid signaling in pain. Curr Opin Neurobiol 12 (2002) 372-379
19. Diener H.C., Pfaffenrath V., Pageler L., Peil H., and Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25 (2005) 776-787
20. Dobos I., Toth K., Kekesi G., Joo G., Csullog E., Klimscha W., et al. The significance of intrathecal catheter location in rats. Anesth Analg 96 (2003) 487-492
21. Dray A. Neuropharmacological mechanisms of capsaicin and related substances. Biochem Pharmacol 44 (1992) 611-615
22. Esser M.J., and Sawynok J. Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur J Pharmacol 399 (2000) 131-139
23. Eun S.Y., Jun Jung S., Kyung Park Y., Kwak J., Jeong Kim S., and Kim J. Effects of capsaicin on Ca2+ release from the intracellular Ca2+ stores in the dorsal root ganglion cells of adult rats. Biochem Biophys Res Commun 285 (2001) 1114-1120
24. Galeotti N., Bartolini A., and Ghelardini C. Ryanodine receptors are involved in muscarinic antinociception in mice. Behav Brain Res 164 (2005) 165-171
25. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 81 (2005) 263-284
26. Guindon J., De Lean A., and Beaulieu P. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. Pain 121 (2006) 85-93
27. Hajos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
28. Hejazi N., Zhou C., Oz M., Sun H., Ye J.H., and Zhang L. {Delta}9-Tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol Pharmacol 69 (2006) 991-997
29. Hohmann A.G. Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem Phys Lipids 121 (2002) 173-190
30. Hohmann A.G., Briley E.M., Herken, and Herkenham M. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res 822 (1999) 17-25
31. Horvath G., and Kekesi G. Interaction of endogenous ligands mediating antinociception. Brain Res Rev 52 (2006) 69-92
32. Horvath G., Kekesi G., Nagy E., and Benedek G. The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. Pain 134 (2008) 277-284
33. Kanai Y., Hara T., and Imai A. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin. J Pharm Pharmacol 58 (2006) 489-493
34. Jerman J.C., Gry J., Brough S.J., Ooi L., Owen D., Davis J.B., et al. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Br J Anaesth 89 (2002) 882-887
35. Kekesi G., Dobos I., Benedek G., and Horvath G. The antinociceptive potencies and interactions of endogenous ligands during continuous intrathecal administration: adenosine, agmatine, and endomorphin-1. Anesth Analg 98 2 (2004) 420-426
36. Kekesi G., Joo G., Csullog E., Peter-Szabo M., Benedek G., and Horvath G. Dose-independent antinociceptive interaction of endogenous ligands at the spinal level. Brain Res 1029 (2004) 93-102
37. Kim H.I., Kim T.H., Shin Y.K., Lee C.S., Park M., and Song J.H. Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. Brain Res 1062 (2005) 39-47
38. Lavand'homme P., and Eisenach J.C. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain 80 (1999) 31-36
39. Lee Y.W., and Yaksh T.L. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther 277 (1996) 1642-1648
40. Lozovaya N., Yatsenko N., Beketov A., Tsintsadze T., and Burnashev N. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. J Neurosci 25 (2005) 7499-7506
41. Mandel H.G. Update on caffeine consumption, disposition and action. Food Chem Toxicol 40 (2002) 1231-1234
42. Murillo-Rodriguez E., Blanco-Centurion C., Sanchez C., Piomelli D., and Shiromani P.J. Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26 (2003) 943-947
43. Ohshita K., Ishiyama H., Oyanagi K., Nakata H., and Kobayashi J. Synthesis of hybrid molecules of caffeine and eudistomin D and its effects on adenosine receptors. Bioorg Med Chem 15 (2007) 3235-3240
44. Olah Z., Karai L., and Iadarola M.J. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem 276 (2001) 31163-31170
45. Oz M. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol Ther 111 (2006) 114-144
46. Oz M., Zhang L., and Morales M. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. Synapse 46 (2002) 150-156
47. Patel M.K., Pinnock R.D., and Lee K. Adenosine exerts multiple effects in dorsal horn neurones of the adult rat spinal cord. Brain Res 920 (2001) 19-26
48. Pertwee R.G. Cannabinoid receptors and pain. Prog Neurobiol 63 (2001) 569-611
49. Pertwee R.G. Pharmacological actions of cannabinoids. Handb Exp Pharmacol 168 (2005) 1-51
50. Poon A., and Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74 (1998) 235-245
51. Puntambekar P., Buren J.V., Raisinghani M., Premkumar L.S., and Ramkumar V. Direct interaction of adenosine with the TRPV1 channel protein. J Neurosci 24 (2004) 3663-3671
52. Quarta D., Ferré S., Solinas M., You Z.B., Hockemeyer J., Popoli P., et al. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88 (2004) 1151-1158
53. Romero-Sandoval A., and Eisenach J.C. Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology 106 (2007) 787-794
54. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 347 (1998) 1-11
55. Sawynok J., and Liu X.J. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69 (2003) 313-340
56. Sawynok J., and Reid A. Caffeine antinociception: role of formalin concentration and adenosine A1 and A2 receptors. Eur J Pharmacol 298 (1996) 105-111
57. Schulte G., Robertson B., Fredholm B.B., DeLander G.E., Shortland P., and Molander C. Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations. Neurosci 121 (2003) 907-916
58. Sosnowski M., and Yaksh T.L. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth Analg 69 (1989) 587-592
59. Szallasi A., Nilsson S., Farkas-Szallasi T., Blumberg P.M., Hökfelt T., and Lundberg J.M. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res 703 (1995) 175-183
60. Szolcsányi J., Helyes Z., Oroszi G., Németh J., and Pintér E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 123 (1998) 936-942
61. Szolcsányi J., Pintér E., Helyes Z., Oroszi G., and Németh J. Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors. Br J Pharmacol 125 (1998) 916-922
62. Tognetto M., Amadesi S., Harrison S., Creminon C., Trevisani M., Carreras M., et al. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci 21 (2001) 1104-1109
63. Tohda C., Sasaki M., Konemura T., Sasamura T., Itoh H., and Kuraishi Y. Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity. J Neurochem 76 (2001) 1628-1635
64. van der Stelt M., and Di Marzo V. Endovanilloids-putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem 271 (2004) 1827-1834
65. van der Stelt M., Trevisani M., Vellani V., De Petrocellis L., Moriello A.S., Campi B., et al. Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels (vol 24, pg 3026, 2005). EMBO J 24 (2005) 3517-3518
66. Walker J.M., Krey J.F., Chu C.J., and Huang S.M. Endocannabinoids and related fatty acid derivates in pain modulation. Chem Phys Lipids 121 (2002) 159-172
67. Welch S.P., and Eads M. Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res 848 (1999) 183-190
68. Yaksh T.L., Kokotos G., Svensson C.I., Stephens D., Kokotos C.G., Fitzsimmons B., et al. Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release. J Pharmacol Exp Ther 316 (2006) 466-475
69. Yang K., Fujita T., and Kumamoto E. Adenosine inhibits GABAergic and glycinergic transmission in adult rat substantia gelatinosa neurons. J Neurophysiol 92 (2004) 2867-2877
70. Yoon M.H., Choi J.I., Kim S.J., Kim C.M., Bae H.B., and Chung S.T. Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test. Eur J Anaesthesiol 23 (2006) 65-70
71. Zupanc G.K.H., Airey J.A., Maler L., Sutko J.L., and Ellisman M.H. Immunohistochemical localization of ryanodine binding proteins in the central nervous system of gymnotiform fish. J Comp Neurol 325 (1992) 135-151
72. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 (1999) 452-457